Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
February 15, 2022
Patent Application Number
16893784
Date Filed
December 5, 2018
Patent Citations Received
Patent Primary Examiner
Patent abstract
Provided herein are compounds of the Formula (I): and stereoisomers, tautomers and pharmaceutically acceptable salts thereof, wherein Ring A, X1, X2, X3, R1, R2 and R3 are as defined herein, which are inhibitors of one or more TAM kinases and are useful in the treatment and prevention of diseases which can be treated with a TAM kinase inhibitor.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
